Waycross Partners’s Elanco Animal Health ELAN Stock Holding History

Waycross Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-228,149	Closed	-$2.14M	–	96
2023 Q1	$2.14M	Buy	228,149 +42,787	+23%	+$505K	0.62%	41
2022 Q4	$2.27M	Buy	185,362 +124,319	+204%	+$1.55M	0.82%	38
2022 Q3	$758K	Sell	61,043 -48,376	-44%	-$846K	0.51%	55
2022 Q2	$2.15M	Sell	109,419 -35,235	-24%	-$834K	1.43%	28
2022 Q1	$3.77M	Buy	144,654 +6,638	+5%	+$177K	2.2%	11
2021 Q4	$3.92M	Buy	138,016 +2,476	+2%	+$77K	2.24%	12
2021 Q3	$4.32M	Sell	135,540 -1,764	-1%	-$59.2K	2.72%	8
2021 Q2	$4.76M	Sell	137,304 -2,375	-2%	-$78.3K	2.53%	13
2021 Q1	$4.11M	Buy	139,679 +30,467	+28%	+$937K	2.29%	15
2020 Q4	$3.35M	Buy	+109,212	New	+$3.33M	2.09%	16

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Waycross Partners's ELAN Position: Q2 2023 in Review

Waycross Partners sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 228,149 shares — an estimated $2.14M sold.

Waycross Partners first reported a position in ELAN in Q4 2020 and held it in 10 quarters. The position peaked at $4.76M in Q2 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

Waycross Partners reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
Waycross Partners sold 228,149 Elanco Animal Health shares in Q2 2023, an estimated $2.14M.
Waycross Partners first reported a position in Elanco Animal Health in Q4 2020 and held it in 10 quarters.
Waycross Partners's Elanco Animal Health position peaked at $4.76M in Q2 2021.
352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Waycross Partners's 13F filing for Q2 2023, filed 26 Jul 2023.